NasdaqCM - Delayed Quote USD

Arcadia Biosciences, Inc. (RKDA)

2.0301 -0.0699 (-3.33%)
At close: April 23 at 4:00 PM EDT
1.9700 -0.14 (-6.64%)
Pre-Market: 8:04 AM EDT
Loading Chart for RKDA
DELL
  • Previous Close 2.1000
  • Open 2.1400
  • Bid --
  • Ask --
  • Day's Range 2.0200 - 2.1400
  • 52 Week Range 1.8510 - 7.3000
  • Volume 6,783
  • Avg. Volume 20,854
  • Market Cap (intraday) 2.767M
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) --
  • EPS (TTM) -10.6400
  • Earnings Date May 9, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 11.00

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

www.arcadiabio.com

21

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RKDA

Performance Overview: RKDA

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RKDA
35.14%
S&P 500
6.30%

1-Year Return

RKDA
67.78%
S&P 500
22.67%

3-Year Return

RKDA
98.06%
S&P 500
22.63%

5-Year Return

RKDA
99.17%
S&P 500
74.37%

Compare To: RKDA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RKDA

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    2.77M

  • Enterprise Value

    -7.87M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.47

  • Price/Book (mrq)

    0.22

  • Enterprise Value/Revenue

    -1.48

  • Enterprise Value/EBITDA

    0.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -262.31%

  • Return on Assets (ttm)

    -34.50%

  • Return on Equity (ttm)

    -78.36%

  • Revenue (ttm)

    5.33M

  • Net Income Avi to Common (ttm)

    -13.16M

  • Diluted EPS (ttm)

    -10.6400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.64M

  • Total Debt/Equity (mrq)

    7.93%

  • Levered Free Cash Flow (ttm)

    -5.73M

Research Analysis: RKDA

Analyst Price Targets

10.00
11.00 Average
2.0301 Current
12.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: RKDA

Fair Value

2.0301 Current
 

Dividend Score

0 Low
RKDA
Sector Avg.
100 High
 

Hiring Score

0 Low
RKDA
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
RKDA
Sector Avg.
100 High
 

People Also Watch